PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25026N0022Exercising FINAL OY — Schaaf Drugs, LLC

Schaaf Drugs, LLC holds $3.7M across 18 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25022D0003. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

250-Network Contract Office 10 (36C250)

Awarding office

Schaaf Drugs, LLC

Recipient

Sep 30, 2026

PoP end

$916K

Obligated

$3.9M

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Schaaf Drugs, LLC — $90

Contract facts

Federal

Contract number36C25026N0022

Also listed as36C250-26-N-0022

Also listed as36C25022D0003-36C25026N0022

Agency250-Network Contract Office 10 (36C250)

Awarding office250-Network Contract Office 10 (36C250)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentSchaaf Drugs, LLC

CAGE60B41

UEILSEHGNVLAVX5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36C25022D0003

Place of performanceLIMA OH

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startOct 1, 2021

PoP end (current)Sep 30, 2026

Obligated$916K

Current value$3.9M

Potential value$3.9M

EXERCISING FINAL OY is a federal award for 250-Network Contract Office 10 (36C250) held by Schaaf Drugs, LLC. Estimated value $3.9M ($916K obligated). Current period of performance ends Sep 30, 2026. Place of performance: LIMA OH.

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Schaaf Drugs, LLC — $3.7M obligated across 18 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$3.7M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

36C25025F0010

ORDERING PERIOD OBLIGATION

$2.9M

Sep 30, 2026

36C25023N0050

EXERCISE ORDERING PERIOD 2 RPOC LINE ITEM COMPLIANCE RADIOPHARM FOR THE DAYTON VAMC

$1.3M

Sep 30, 2026

36C25022N0012

RADIOPHARM

$646K

Sep 30, 2026

36C25026N0181

YEAR 4, OPTION YEAR 3 PATIENT RADIOPHARMACEUTICAL DRUGS (12 MONTHS)

$681K

Nov 22, 2026

36C25023N0185

RADIOPHARMACEUTICAL DRUGS

$588K

Nov 22, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25026N0022?

36C25026N0022 (Exercising FINAL OY) is a 250-Network Contract Office 10 (36C250) award with a potential value of $3.9M, currently held by Schaaf Drugs, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-26-N-0022?

36C250-26-N-0022 is the dashed form of PIID 36C25026N0022 (Exercising FINAL OY), held by Schaaf Drugs, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25026N0022?

250-Network Contract Office 10 (36C250) awarded 36C25026N0022 to Schaaf Drugs, LLC (potential $3.9M).

Who is the incumbent on 36C25026N0022?

Schaaf Drugs, LLC is the incumbent with $3.7M across 18 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Schaaf Drugs, LLC’s 36C25026N0022 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Oct 1, 2025